CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript

The provided text is the introductory segment of CV Sciences, Inc.'s Q2 2025 earnings conference call, held on August 13, 2025, featuring CEO Joseph Dowling and CFO Joerg Grasser. While it outlines the call's structure and includes standard forward-looking statement disclaimers, the document itself contains no actual financial results or operational performance details.

Analysis

The provided text is the procedural introduction to the CV Sciences, Inc. (OTCQB:CVSI) Q2 2025 earnings conference call, not a report on financial performance. The document confirms that CEO Joseph Dowling and CFO Joerg Grasser will present prepared remarks, but it contains no actual financial results, operational metrics, or forward-looking guidance. The content is limited to standard formalities, including a safe harbor statement on forward-looking statements and a reference to a separate press release issued earlier that contains the full financial details and a reconciliation of non-GAAP to GAAP measures. The neutral sentiment score of 0.0 accurately reflects the non-substantive, administrative nature of this transcript excerpt. Therefore, this document serves only to announce the event and its participants, with all material information for investment analysis located in the aforementioned press release and the subsequent, unrecorded portion of the call.

Key Decisions for Investors

• Investors must locate and review the official CV Sciences Q2 2025 earnings press release to access the actual financial results, as this transcript excerpt contains no performance data.
• Pay close attention to the full conference call recording, particularly the management's prepared remarks and the analyst Q&A session, for qualitative context and forward-looking guidance that is absent here.
• Any trading or investment decision regarding CVSI is premature and should be deferred until a complete analysis of the company's reported earnings, revenue, and management outlook is conducted.